Zakrzewski Joseph S has filed 16 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 99999 shares of AN2 Therapeutics, Inc. ($ANTX) on March 19, 2026.
Activity breakdown: 3 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | A | Stock Option (right to buy) | 99999 | $0.00 | 99,999.0000 | 30,276,230 | 9999.99% | 0.33% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | D | Stock Option (right to buy) | 99999 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.33% |
| Feb. 20, 2026 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| May 22, 2025 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| April 10, 2025 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | A | Common Stock | 10523 | $0.00 | 551,418.0000 | 29,828,227 | 1.95% | 0.04% |
| Dec. 19, 2024 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | A | Common Stock | 9816 | $0.00 | 540,895.0000 | 29,841,169 | 1.85% | 0.03% |
| Nov. 27, 2024 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | P | Common Stock | 2000 | $1.40 | 531,079.0000 | 29,841,169 | 0.38% | 0.01% |
| Nov. 18, 2024 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | P | Common Stock | 20000 | $1.00 | 524,079.0000 | 29,841,169 | 3.97% | 0.07% |
| Nov. 19, 2024 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | P | Common Stock | 5000 | $1.01 | 529,079.0000 | 29,841,169 | 0.95% | 0.02% |
| June 19, 2024 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| Jan. 18, 2024 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Not found | S | Common Stock | 100000 | $19.11 | 504,079.0000 | 23,600,107 | 16.55% | 0.42% |
| June 7, 2023 | AN2 Therapeutics, Inc. | $ANTX | Zakrzewski Joseph S | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |